Sex Disparities and the Risk of Urolithiasis: a Large Cross-sectional Study

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2022 Jun 8

PMID 35675329

Authors

Jin-Zhou Xu

Cong Li

Qi-Dong Xia

Jun-Lin Lu

Zheng-Ce Wan

Liu Hu

Yong-Man Lv

Xiao-Mei Lei

Wei Guan

Yang Xun

Shao-Gang Wang

Affiliations

Soon will be listed here.

Abstract

Background: Urolithiasis is one of the most common diseases in urology, with a lifetime prevalence of 14% and is more prevalent in males compared to females. We designed to explore sex disparities in the Chinese population to provide evidence for prevention measures and mechanisms of stone formation.

Materials And Methods: A total of 98232 Chinese individuals who had undergone a comprehensive examination in 2017 were included. Fully adjusted odds ratios for kidney stones were measured using restricted cubic splines. Multiple imputations was applied for missing values. Propensity score matching was utilised for sensitivity analysis.

Results: Among the 98232 included participants, 42762 participants (43.53%) were females and 55470 participants (56.47%) were males. Patients' factors might cast an influence on the development of kidney stone disease distinctly between the two genders. A risk factor for one gender might have no effect on the other gender. The risk for urolithiasis in females continuously rises as ageing, while for males the risk presents a trend to ascend until the age of around 53 and then descend.

Conclusions: Patients' factors might influence the development of kidney stones distinctly between the two genders. As age grew, the risk to develop kidney stones in females continuously ascended, while the risk in males presented a trend to ascend and then descend, which was presumably related to the weakening of the androgen signals.Key messagesWe found that patients' factors might cast an influence on the development of kidney stone disease distinctly between the two sexes.The association between age and urolithiasis presents distinct trends in the two sexesThe results will provide evidence to explore the mechanisms underlying such differences can cast light on potential therapeutic targets and promote the development of tailored therapy strategies in prospect.

Citing Articles

Associations between multiple inflammatory biomarkers and the risk of developing kidney stones.

Lee J, Bae H BMC Urol. 2025; 25(1):48.

PMID: 40075397 PMC: 11900638. DOI: 10.1186/s12894-025-01735-5.

The ratio of perirenal fat thickness to renal parenchymal thickness, a novel indicator of fat accumulation associated with kidney stones.

Hu D, Li G, Ge D, Ke L, Shu H, Chen Y Lipids Health Dis. 2025; 24(1):86.

PMID: 40055701 PMC: 11887230. DOI: 10.1186/s12944-025-02497-7.

High dietary calcium to phosphorus ratio is associated with high prevalence of kidney stone.

Zhang W, Lou B, Peng Y, Wu F, Zhang D, Wang Q Medicine (Baltimore). 2024; 103(50):e40778.

PMID: 39686460 PMC: 11651432. DOI: 10.1097/MD.0000000000040778.

A study of the difference in biochemical metabolism between patients with unilateral and bilateral upper urinary tract stones.

Zheng Z, Hu W, Ji C, Zhang X, Ding X, Zhou S Sci Rep. 2024; 14(1):30154.

PMID: 39627370 PMC: 11615316. DOI: 10.1038/s41598-024-81454-3.

Causal association of serum vitamin D levels with urolithiasis: a bidirectional two-sample Mendelian randomization study.

Zhang Q, Zhang H, Wang S, Zeng L Eur J Nutr. 2024; 64(1):39.

PMID: 39614876 DOI: 10.1007/s00394-024-03553-1.

References

Lubinus Badillo F, Cala O, Vera Campos S, Villarreal Ibanez E . Relationship Between Urolithiasis and Fatty Liver Disease: Findings in Computed Tomography. Tomography. 2020; 6(1):1-4. PMC: 7138524. DOI: 10.18383/j.tom.2020.00020. View

Mitchell T, De Miguel C, Gohar E . Sex differences in redox homeostasis in renal disease. Redox Biol. 2020; 31:101489. PMC: 7212488. DOI: 10.1016/j.redox.2020.101489. View

Xu J, Lu J, Hu L, Xun Y, Wan Z, Xia Q . Sex Disparities in the Association of Serum Uric Acid With Kidney Stone: A Cross-Sectional Study in China. Front Med (Lausanne). 2022; 9:774351. PMC: 8864179. DOI: 10.3389/fmed.2022.774351. View

Kim S, Chang Y, Yun K, Jung H, Kim I, Hyun Y . Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes (Lond). 2018; 43(4):852-861. DOI: 10.1038/s41366-018-0140-z. View

Gillams K, Juliebo-Jones P, Juliebo S, Somani B . Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review. Curr Urol Rep. 2021; 22(10):50. PMC: 8497339. DOI: 10.1007/s11934-021-01066-6. View

Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S . Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Cell Death Dis. 2019; 10(4):275. PMC: 6427030. DOI: 10.1038/s41419-019-1358-y. View

Nackeeran S, Katz J, Ramasamy R, Marcovich R . Association between sex hormones and kidney stones: analysis of the National Health and Nutrition Examination Survey. World J Urol. 2020; 39(4):1269-1275. DOI: 10.1007/s00345-020-03286-w. View

Zeng Q, He Y . Age-specific prevalence of kidney stones in Chinese urban inhabitants. Urolithiasis. 2013; 41(1):91-3. DOI: 10.1007/s00240-012-0520-0. View

Lin C, Liu J, Wu C, Hsu R, Hsu W . Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer. Int J Environ Res Public Health. 2020; 17(5). PMC: 7084407. DOI: 10.3390/ijerph17051762. View

10.

Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M . EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2015; 69(3):468-74. DOI: 10.1016/j.eururo.2015.07.040. View

11.

Tundo G, Khaleel S, Pais Jr V . Gender Equivalence in the Prevalence of Nephrolithiasis among Adults Younger than 50 Years in the United States. J Urol. 2018; 200(6):1273-1277. DOI: 10.1016/j.juro.2018.07.048. View

12.

Wang X, Luo Y, Wang Y, Wang C, Zhao X, Wang D . Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry. Am J Kidney Dis. 2013; 63(1):59-67. DOI: 10.1053/j.ajkd.2013.08.008. View

13.

Wang Z, Zhang Y, Zhang J, Deng Q, Liang H . Recent advances on the mechanisms of kidney stone formation (Review). Int J Mol Med. 2021; 48(2). PMC: 8208620. DOI: 10.3892/ijmm.2021.4982. View

14.

Manissorn J, Fong-Ngern K, Peerapen P, Thongboonkerd V . Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep. 2017; 7(1):1798. PMC: 5431959. DOI: 10.1038/s41598-017-01953-4. View

15.

Brisbane W, Bailey M, Sorensen M . An overview of kidney stone imaging techniques. Nat Rev Urol. 2016; 13(11):654-662. PMC: 5443345. DOI: 10.1038/nrurol.2016.154. View

16.

Parks J, Coe F, Evan A, Worcester E . Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2008; 24(1):130-6. PMC: 2721421. DOI: 10.1093/ndt/gfn420. View

17.

Prochaska M, Taylor E, Curhan G . Menopause and Risk of Kidney Stones. J Urol. 2018; 200(4):823-828. PMC: 6556766. DOI: 10.1016/j.juro.2018.04.080. View

18.

Wagner C, Mohebbi N . Urinary pH and stone formation. J Nephrol. 2010; 23 Suppl 16:S165-9. View

19.

Changtong C, Peerapen P, Khamchun S, Fong-Ngern K, Chutipongtanate S, Thongboonkerd V . In vitro evidence of the promoting effect of testosterone in kidney stone disease: A proteomics approach and functional validation. J Proteomics. 2016; 144:11-22. DOI: 10.1016/j.jprot.2016.05.028. View

20.

Peerapen P, Thongboonkerd V . Protective Cellular Mechanism of Estrogen Against Kidney Stone Formation: A Proteomics Approach and Functional Validation. Proteomics. 2019; 19(19):e1900095. DOI: 10.1002/pmic.201900095. View